Overview
The Antiterrorism and Effective Death Penalty Act of 1996 (1996 Act) strengthened federal criminal laws pertaining to biological weapons in response to the United States v. Harris case, which revealed significant gaps in existing legislation that allowed anyone to obtain dangerous pathogens without legitimate purpose.
Key Amendments
Expansion of Government Prosecution Capacity: Amended three sections of the 1989 Act to update federal criminal statutes with current science and technology, ensuring bioterrorists face severe punishment. Included genetically altered products in definitions of biological agents, toxins, and vectors; added criminal penalties for attempts, threats, or conspiracies to violate biological weapons laws.
Criminalizing Genetically Altered Biological Weapons: Expanded 18 U.S.C. § 2332a (weapons of mass destruction) by including use of biological agents and toxins as defined in 18 U.S.C. § 178, thereby covering genetically altered products under the general prohibition against weapons of mass destruction.
Tightened Safety and Transfer Regulations: Mandated that the Secretary of Health and Human Services establish a list of dangerous biological agents posing severe public health threats within three months, promulgate final regulations within six months, and create rules requiring proper training, containment procedures, and disposal guidelines for facilities handling listed agents.
Implementation Challenges
The CDC promulgated final regulations on October 24, 1996 (effective April 15, 1997), but full implementation has been delayed due to resource constraints. As of May 1999, only half of the approximately 300 institutions possessing listed agents were registered with the CDC. Senator Jon Kyl noted that as of March 1998, nearly 25% of laboratories required to register had not done so.
Limitations
Regulations cover only transferors and shippers of lethal agents, leaving nonlethal harmful agents unregulated. Individuals who cultivate listed agents without transferring them must still comply with registration requirements (though this provision was under consideration due to CDC concerns about conflicting with public health missions). The regulations do not address home laboratories or possession by individuals with criminal backgrounds.